New Hepatitis C Treatment

Published Online: Friday, February 24, 2012
Follow Pharmacy_Times:
The standard treatment for hepatitis C, interferon and ribavirin, cures just 45% of those who receive it. There are now several dozen new drugs for the disease under development, and 2 were approved by the FDA in 2011: telaprevir and boceprevir. The new drugs, which directly attack the virus that causes hepatitis C with minimal impact on the human host, have raised hopes of shorter treatment times and higher cure rates. Researchers are also looking at ways of tailoring treatment to individual patients based on genetic testing.
 
To learn more, check out this video:

Related Articles
Sometimes, the pharmacist just can’t leave the counter. At certain locations, that dedication persists even after death, leading to tales of spectral pharmacists causing mischief and strange events at their former pharmacies.
B. Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association (NCPA), discusses increasing generic drug prices and the problems they create for independent community pharmacists.
Latest Issues
$auto_registration$